Intraepidermal nerve fiber density as a marker of early diabetic neuropathy

被引:122
作者
Umapathi, T.
Tan, Wan Loo
Loke, Seng Cheong
Soon, Puay Cheow
Tavintharan, S.
Chan, Yiong Huak
机构
[1] Natl Inst Neurosci, Singapore 308433, Singapore
[2] Tan Tock Seng Hosp, Singapore, Singapore
[3] Alexandra Hosp, Singapore, Singapore
[4] Natl Univ Singapore, Singapore 117548, Singapore
关键词
diabetic complications; diabetes mellitus; diabetic neuropathy; intraepidermal nerve fiber density;
D O I
10.1002/mus.20732
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of the study was to reliably identify an early stage of diabetic polyneuropathy (DPN) by measuring injury to epidermal nerve fibers. We compared intraepidermal nerve fiber density (IENFD) at the ankle and thigh of 29 diabetic subjects who had no clinical or electrophysiological evidence of small- or large-fiber neuropathy to that of 84 healthy controls. The mean ankle IENFD of diabetic subjects was 9.1 +/- 5.0 mm and that of controls, 13.0 +/- 4.8 mm (P < 0.001). The thigh IENFD did not differ significantly. The IENFD ratio (thigh IENFD divided by ankle IENFD) was 2.39 +/- 1.30 in diabetic subjects and 1.77 +/- 0.58 in controls (P < 0.001), indicating a length-dependent reduction of IENFD in diabetics. Ankle IENFD remained significantly lower and the IENFD ratio higher in diabetic subjects after adjusting for age. Two subjects had parasympathetic dysfunction, two had retinopathy, and two early nephropathy. Age, height, weight, duration of diabetes, and average HbA1c did not influence IENFD among diabetic subjects. We used receiver operating characteristic (ROC) curves to describe and compare the utility of various threshold values of ankle IENFD and IENFD ratio for the diagnosis of early DPN. The sensitivity and specificity of diagnosing DPN using ankle IENFD of less than 10 mm were 72.4% and 76.2%, respectively. Thus, asymptomatic diabetics have a measurable, length-dependent reduction of distal epidermal nerves. Analogous to microalbuminuria in diabetic nephropathy, reliable identification and quantitation of nascent diabetic neuropathy may have potential therapeutic implications.
引用
收藏
页码:591 / 598
页数:8
相关论文
共 41 条
[1]   Risk factors for diabetic peripheral sensory neuropathy - Results of the Seattle Prospective Diabetic Foot Study [J].
Adler, AI ;
Boyko, EJ ;
Ahroni, JH ;
Stensel, V ;
Forsberg, RC ;
Smith, DG .
DIABETES CARE, 1997, 20 (07) :1162-1167
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[5]  
[Anonymous], 1999, DIABETIC NEUROPATHY
[6]   PAINFUL DIABETIC NEUROPATHY - MORPHOMETRIC STUDY [J].
BROWN, MJ ;
MARTIN, JR ;
ASBURY, AK .
ARCHIVES OF NEUROLOGY, 1976, 33 (03) :164-171
[7]  
Cohen JA, 1998, MUSCLE NERVE, V21, P72, DOI 10.1002/(SICI)1097-4598(199801)21:1<72::AID-MUS10>3.3.CO
[8]  
2-P
[9]   Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester diabetic neuropathy study cohort [J].
Dyck, PJ ;
Davies, JL ;
Litchy, WJ ;
OBrien, PC .
NEUROLOGY, 1997, 49 (01) :229-239
[10]   THE ROCHESTER DIABETIC NEUROPATHY STUDY - REASSESSMENT OF TESTS AND CRITERIA FOR DIAGNOSIS AND STAGED SEVERITY [J].
DYCK, PJ ;
KARNES, JL ;
OBRIEN, PC ;
LITCHY, WJ ;
LOW, PA ;
MELTON, LJ .
NEUROLOGY, 1992, 42 (06) :1164-1170